Scientists Developing Super Jab That Combines Mounjaro and Ozempic

WooGlobe

A new 4-in-1 weight loss drug could soon replace invasive surgeries like gastric bypass—offering up to 30% body weight loss without going under the knife. Developed by researchers at Tufts University, this breakthrough treatment combines the effects of Mounjaro and Ozempic and goes even further by targeting four powerful hormone receptors, including peptide YY—which may help burn fat directly, not just curb your appetite.  While the drug hasn’t entered human trials yet, experts say it could take several years to be approved. But if it works, this could be one of the biggest revolutions in obesity treatment ever seen. WooGlobe Ref : WGA485059 For licensing and to use this video, please email licensing@wooglobe.com

Transcript

00:00What if one single injection could replace surgery and melt away 30% of your body weight?

00:05Scientists are developing a 4-in-1 superdrug that combines the power of Monjaro and Ozempic.

00:11And it could be the biggest breakthrough in weight loss yet.

00:14A team at Tufts University is working on a revolutionary treatment that targets four key hormone receptors.

00:20Current drugs like Ozempic and Monjaro target one or two.

00:23But this new drug adds two more, including one called Peptide YY.

00:28This hormone not only reduces appetite, it could actually help burn fat directly.

00:33The results? Up to 30% body weight loss, matching what people get from bariatric surgery.

00:39But unlike surgery, this would be non-invasive.

00:42So when can we expect it? Unfortunately, it hasn't entered trials yet.

00:46And new drugs can take 7 years, or more, before hitting the shelves.

00:50But if it works, this could change the future of weight loss forever.

Category

Transcript

Comments

Recommended